Skip to main content

Table 1 Distribution of the clinical parameters

From: DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population

Clinical parameters

 

Distribution (%)

Age (years)

20 to 40

2.30

41 to 60

31.70

61 to >80

66.10

Breast cancer diagnosis

Right breast

47.10

Left breast

46.10

Both

6.80

Histology

Ductal

67.40

Lobular

15.40

DCIS

6.40

LCIS

1.80

Mixed and other tumor types

9.00

TNM stage

I

36.70

IIa

24.40

IIb

10.90

IIIa

8.60

IIIb

5.00

IIIc

8.10

IV

6.30

ER status

Positive

82.40

Negative

17.60

PR status

Positive

72.40

Negative

27.60

HER2 status

Positive

14.00

Negative

67.00

Not defined

19.00

Response of chemotherapy

No chemotherapy/data

48.00

Complete remission

32.10

Recurrence

5.90

Stable disease

8.10

Progress

5.90

Survival

Not detected

10.90

Alive

76.00

Death

13.10

  1. DCIS, ductal carcinoma in situ; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; LCIS, lobular carcinoma in situ; PR, progesterone receptor; TNM, TNM Classification of Malignant Tumours.